International Journal of Clinical Pharmacy

Article	Citations
Comment on: “whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis”	73
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia	68
Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies	57
Implementation fidelity of a pharmacist-led intervention program to improve a high serum phosphate concentration in haemodialysis patients: a mixed-methods study	49
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study	41
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children	39
Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'	37
Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review	35
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study	34
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials	33
Non-cardiovascular medication and readmission for heart failure: an observational cohort study	33
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial	30
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country	29
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study	28
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study	27
Future pharmacists and climate action: a qualitative study of students’ views on environmental sustainability in education and practice	25
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer	25
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes	25
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs	24
Sedative co-medication patterns across frailty states in people with HIV: a network-based study	24
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients	24
Reliability and validity testing of the medicines related - consultation assessment tool for assessing pharmacists’ consultations	23
Ethical conflicts in patient care situations of community pharmacists: a cross-sectional online survey	23
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis	21
Effects of children’s criteria for identifying potentially inappropriate prescribing on prescription review by pharmacists: a before-after study	21

Correlation between the prognostic nutritional index and outcomes in older patients aged ≥ 60 years with chronic heart failure	20
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study	20
Comparative effectiveness and safety of fluticasone-based versus beclometasone-based single-inhaler triple therapies in patients with chronic obstructive pulmonary disease: a population-based cohort s	20
Conversational agents for pharmaceutical use: insights from the eCCo database	20
Medication errors in emergency departments: a systematic review and meta-analysis of prevalence and severity	19
Risk prediction models for adverse drug reactions in pediatrics: a scoping review	19
Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years	18
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer	17
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study	17
Impact of Australian home medicines reviews on continuous polypharmacy and associated costs among older women: a cohort study	17
Through the lens: photovoice reveals the role of pharmacists in primary care	17
Novel opportunities for clinical pharmacy research: development of a machine learning model to identify medication related causes of delirium in different patient groups	15
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations	15
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors	15
Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List	15
Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions	14
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study	14
A machine learning model exploring the relationship between chronic medication and COVID-19 clinical outcomes	14
Correction to: 49th ESCP virtual symposium on clinical pharmacy 19.10.2021–21.10.2021 Clinical pharmacy, working collaboratively in mental health care	14
A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram	14
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study	14
Pharmacist-led deprescribing of cardiovascular and diabetes medication within a clinical medication review: the LeMON study (Less Medicines in Older Patients in the Netherlands), a cluster randomized	13
An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases	13
Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	13
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions	13
Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study	13
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey	13
The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis	13
Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data	12
Medication supply at hospital discharge via community pharmacy: a quality improvement study	12
Pharmacist input to depression screening and management in patients with diabetes: a systematic review	12
Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence	12
How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy	12
Detection and management of pill swallowing difficulties: a community pharmacy-based observational study	11
Application of a screening tool to understand the medication habits of patients with swallowing difficulty: a prospective observational study	11
Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis	11
Correction to: 50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care	11
Drivers of engagement in virtual communities of practice: a qualitative study of Australian pharmacists’ perceptions and experiences	11
Comment on “Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study”	11
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study	11
Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study	11
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study	11
Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study	10
Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums	10
Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines	10
Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults	10
Correction: European Society of Clinical Pharmacy: 5 steps of medication safety—medication without harm, where are we now?	10
Comment on “The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis”	10
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012–2021)	10
What do emergency department pharmacist practitioners know and understand about patient safeguarding? A qualitative study	10

Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C	10
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review	10
Embedding cultural competency and cultural humility in undergraduate pharmacist initial education and training: a qualitative exploration of pharmacy student perspectives	10
Population pharmacokinetics of imipenem and target attainment of pharmacokinetic/pharmacodynamic indices in Chinese adults with febrile neutropenia and hematological malignancies	10
Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance	10
Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT)	10
Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities	10
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma	10
Opinions and experiences on the provision of care to people with mental illnesses: a qualitative study with Doctor of Pharmacy graduates after a rotation in psychiatry	10
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China	10
A quality improvement study on the effect of electronic transmission of a basic discharge medication report on medication discrepancies in patients discharged from the hospital	9
Clinical Pharmacist and Clinical Nurse Specialist led medicine optimisation and medication adherence via eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool in Senior Adult Oncology Progr	9
How patient-centredness takes place in pharmacy encounters: a critical common-sense interpretation of video-recorded meetings	9
Building an effective medicines optimisation model: a health system approach	9
Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system	9
A real-world pharmacovigilance study of belzutifan in renal cell carcinoma and von Hippel-Lindau disease: insights from the FDA adverse event reporting system database	9
A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative stu	9
Communication issues between pharmacists and d/Deaf people: a qualitative study in Thailand	9
Exploring the time required by pharmacists to prepare discharge medicine lists: a time-and-motion study	9
Bibliometric analysis of anti-angiogenic therapy in gastric cancer: research hotspots, trends, and emerging frontiers	9
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources	9
Exploring the suitability of a ward-based clinical pharmacy activity collection tool for ambulatory care practice: a mixed-methods study	9
Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study	9
Evaluating an integrated clinical pharmacist model in a geriatric day hospital: a prospective single-centre observational study	9
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)	8
Pharmacovigilance analysis of metabolic and nutritional adverse reactions associated with entecavir and tenofovir using the FDA adverse event reporting system database	8
Risk factors for potentially inappropriate medication use in older adults: a cohort study	8
Implementation of pharmacist-led deprescribing in collaborative primary care settings	8
A qualitative evaluation of barriers and facilitators to a large-scale antithrombotic stewardship intervention in the United States Veterans Healthcare system	8
Assessing the cost-effectiveness of replacing antimetabolites with mTOR inhibitors in heart transplant immunosuppression in China: a network meta-analysis-based economic evaluation	8
Impact of artificial intelligence on the academic performance and test anxiety of pharmacy students in objective structured clinical examination: a randomized controlled trial	8
Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China	8
A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital	8
Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care	8
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study	8
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study	8
Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system	8
Addressing the second victim phenomenon among community pharmacists and its impact on clinical pharmacy practice: a consensus study	8
The effect of empagliflozin on renal outcomes compared to sitagliptin with type 2 diabetes: target trial emulation using electronic medical records	8
Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study	8
Perceived importance of tailored education to prevent second victim phenomenon in clinical pharmacy practice: a focus group study with community pharmacists	8
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists	8
Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic	8
Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso	8
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials	8
SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports	8
Disparities associated with race and ethnicity in pain management: a scoping review	7
Patient and hospital staff perspectives on introducing pharmacist-led medication reviews at an orthopedic ward: a mixed methods pilot study	7
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’	7
Evaluating the quality, feasibility and patient satisfaction of medication history taking by telephone for patients with scheduled admissions: a pilot study	7
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries	7
Abstracts of the 26th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, Berlin, Germany, 17–19 November 2022	7
Publisher Correction to: Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial	7
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database	7
ADHD prescribing: national findings of children and adolescents attending mental health services in Ireland	7
Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study	7
Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study	7
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: perspectives from the United States and C	7
Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care	7
Accuracy of best possible medication histories by pharmacy students: an observational study	7
Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study	7
Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study	7
A qualitative exploration of the enablers and barriers to the provision of outpatient clinics by hospital pharmacists	7
Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis	7
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis	7
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study	7
Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy	7
ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 2023	7
Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review	7
Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population	7
Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study	6
Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	6
Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach	6
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System	6
Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study	6
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review	6
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study	6
Thank you from the Editor-in-Chief	6
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China	6
European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper	6

Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis	6
Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis	6
Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study	6
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence	6
Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ	6
Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national	6
Effectiveness and safety of different antiplatelet therapies for minor ischemic stroke or high-risk transient ischemic attack: a systematic review and network meta-analysis	6
Influence of a ward-based pharmacist on the medication quality of geriatric inpatients: a before–after study	6
Co-designing psychosis simulated patient scenarios with mental health stakeholders for pharmacy curricula	6
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-	6
Associated factors and safety of the rapidly achieving first therapeutic target of warfarin in hospitalized patients: a retrospective cohort study	6
Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review	6
Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study	6
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist	6
Correction: Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-inte	6
Provision of drug and alcohol services amidst COVID-19 pandemic: a qualitative evaluation on the experiences of service providers	6
Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study	6
Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study	6
Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials	6
Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour	6
Flight safety risk assessment of self-medication among fighter pilots: a cross-sectional study	6
Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study	6
Medicines-related interventions to support safe transitions for care home residents post hospital discharge: Do hospital-delivered interventions have a role?	6
Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings	6